Press release
Drugs of Abuse (DOA) Testing Market 2024 - By Industry Analysis, Competitive Landscape, Growth Factors, Revenue And Outlook By 2033
Drugs of Abuse (DOA) Testing Market
The Business Research Company offers in-depth market insights through Drugs of Abuse DOA Testing Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The drugs of abuse (DOA) testing market size has grown strongly in recent years. It will grow from $6.6 billion in 2023 to $7.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to government regulations and workplace policies, pre-employment screening, law enforcement and legal procedures, drug rehabilitation programs, transportation industry compliance.
The drugs of abuse (DOA) testing market size is expected to see strong growth in the next few years. It will grow to $10.48 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The growth in the forecast period can be attributed to expanding sports and athletics testing, increasing awareness and education, rise in drug-related crimes, corporate wellness programs, advancements in testing methods. Major trends in the forecast period include use of portable and handheld testing devices, implementation of laboratory information management systems (LIMS), emphasis on synthetic drug testing, increasing demand for cann*abis testing, integration of artificial intelligence (AI) for result interpretation.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=9381&type=smp
Market Segmentation:
The drugs of abuse (DOA) testing market covered in this report is segmented -
1) By Product And Service: Analyzers, Rapid Testing Devices, Consumables, Laboratory Services
2) By Sample Type: Urine, Hair, Oral Fluid, Breath
3) By Application: Pain Management, Criminal Justice, Workplace Screening
4) By End User: Hospitals, Diagnostic Laboratories, Forensic Laboratories, Other End Users
Major Driver - Surging Global Demand For Drug Abuse Treatment Sparks Growth In Drugs Of Abuse Testing Market
Increasing demand for drug abuse treatment is expected to propel the growth of the drugs of abuse (DOA) testing market going forward. Drug abuse or substance abuse refers to the use of a substance in quantities that are harmful to the user or others. Drug testing aids in the identification of compounds that are not normally found in the body. The process starts with a screening test, which is followed by a second test to find and/or confirm the presence of a substance or substances, so increasing demand for drug abuse treatment will propel the market's growth. For instance, in June 2021, according to the United Nations Office on Drugs and Crime (UNODC), a US-based drug control and crime prevention organization, combining the United Nations International Report 2021 World Drug Report, over 36 million individuals in the world have drug use disorders. Therefore, increasing demand for drug abuse treatment is driving the drug of abuse (DOA) testing market.
Competitive Landscape:
Major companies operating in the drugs of abuse (DOA) testing market report are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Zimmer Biomet Holdings Inc., bioMérieux Inc., Dragerwerk AG & Co. KGaA, Natera Inc., Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., Homology Medicines Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/drugs-of-abuse-doa-testing-global-market-report
Top Trend - Omega Laboratories Inc. Takes The Lead In Drug Testing Innovation With Advanced Urine Drugs Of Abuse Testing Services
Major companies operating in the drugs of abuse (DOA) testing market are developing new products such as advanced drug testing to gain a competitive edge in the market. Drug testing refers to the process of analyzing biological specimens, such as urine, to detect the presence of specific drugs or their metabolites. For instance, in December 2022, Omega Laboratories Inc., a US-based company specializing in forensic toxicology and hair testing services launched urine drugs of abuse testing services. These are relatively easy to do, have quick effects, and are reasonably priced. The lab offers urine drug testing services and is accredited by SAMHSA, guaranteeing the best caliber and precision in test findings. The organization offers over 6,000 clients worldwide laboratory-based sophisticated testing solutions. Both screening and confirmatory testing are used in urine drug abuse testing services to guarantee the precision and dependability of the results.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Drugs of Abuse DOA Testing Market Characteristics
3. Drugs of Abuse DOA Testing Market Trends And Strategies
4. Drugs of Abuse DOA Testing Market - Macro Economic Scenario
5. Drugs of Abuse DOA Testing Market Size And Growth
…..
27. Drugs of Abuse DOA Testing Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Drugs of Abuse (DOA) Testing Market 2024 - By Industry Analysis, Competitive Landscape, Growth Factors, Revenue And Outlook By 2033 here
News-ID: 3414507 • Views: …
More Releases from The Business research company
Potato Starch Market Forecasted for Strong Growth, Projected to Reach $8.26 Bill …
The potato starch market size has grown strongly in recent years. It will grow from $6.29 billion in 2023 to $6.64 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rise in demand for processed food items, growing demand for gluten-free food products, increased production and export prospects , diversification of potato starch…
Retail Inventory Management Software Market: Detailed Outlook on Size, Share, Se …
The retail inventory management software market size has grown rapidly in recent years. It will grow from $7.45 billion in 2023 to $8.37 billion in 2024 at a compound annual growth rate (CAGR) of 12.5%. The growth in the historic period can be attributed to the increasing number of e-commerce retailers, globalization of supply chains, rising customer expectations, competition, and market differentiation, and increasing product complexity.
The retail inventory management…
Prebiotic Ingredients Market Size, Share, Trends, Outlook, Insights 2024-2033
The prebiotic ingredients market size has grown rapidly in recent years. It will grow from $6.44 billion in 2023 to $7.16 billion in 2024 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increased focus on gut health, rise in digestive health concerns, growing awareness about the health benefits of prebiotic ingredients, rising demand for natural…
Polyphenols Market Size, Share, Trends And Forecast To 2024-2033
The polyphenols market size has grown rapidly in recent years. It will grow from $2.14 billion in 2023 to $2.45 billion in 2024 at a compound annual growth rate (CAGR) of 14.6%. The growth in the historic period can be attributed to demand for natural antioxidants and growth in the food and beverage industries, expansion of functional foods and nutraceuticals, development of polyphenol-rich extracts, increase…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
